Learn More
Clinical trials are underway for the treatment of tuberous sclerosis (TSC)-associated tumours using mTOR inhibitors. Here, we show that many of the earliest renal lesions from Tsc1+/- and Tsc2+/- mice do not exhibit mTOR activation, suggesting that pharmacological targeting of an alternative pathway may be necessary to prevent tumour formation. Patients(More)
Tourette syndrome (TS) is a neurodevelopmental disorder characterised by multiple motor and vocal tics. Co-morbid behavioural problems are common and include obsessive-compulsive disorder, attention-deficit and hyperactivity disorder, depression and anxiety. Both tics and behavioural symptoms tend to have a chronic course and can affect patients'(More)
  • 1